Pharmacological treatment of acute spinal cord injury: current status and future prospects

M B Bracken

doi:10.1038/sc.1992.34

Pharmacological treatment of acute spinal cord injury: current status and future prospects

Paraplegia. 1992 Feb;30(2):102-7. doi: 10.1038/sc.1992.34.

Author

M B Bracken¹

Affiliation

¹ Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06510.

PMID: 1589282
DOI: 10.1038/sc.1992.34

Abstract

The history and results of the National Acute Spinal Cord Injury Studies (NASCIS) are briefly reviewed. The current status of pharmacological therapy for acute spinal cord injury and future prospects are also summarized.

Publication types

Clinical Trial
Randomized Controlled Trial
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Follow-Up Studies
Humans
Methylprednisolone / therapeutic use
Naloxone / therapeutic use
Spinal Cord Injuries / drug therapy*
Spinal Cord Injuries / physiopathology

Substances

Naloxone
Methylprednisolone

Grants and funding

NS 15078/NS/NINDS NIH HHS/United States